Results 291 to 300 of about 201,059 (326)
Some of the next articles are maybe not open access.
Bronchopulmonary Dysplasia and Surfactant
Neonatology, 2001Bronchopulmonary dysplasia (BPD) is the most common respiratory complication in preterm infants who survive prolonged mechanical ventilation. Exogenous surfactant administration clearly reduces the severity of respiratory distress syndrome (RDS) and consequently the need for aggressive ventilation and prolonged oxygen therapy.
E, Bancalari, T, del Moral
openaire +2 more sources
Imaging of bronchopulmonary dysplasia
Seminars in Perinatology, 2023Bronchopulmonary dysplasia (BPD) is a multifactorial disease with many associated co-morbidities, responsible for most cases of chronic lung disease in childhood. The use of imaging exams is pivotal for the clinical care of BPD and the identification of candidates for experimental therapies and a closer follow-up.
Alonso-Ojembarrena, Almudena +2 more
openaire +2 more sources
Advances in bronchopulmonary dysplasia
Expert Review of Respiratory Medicine, 2014Bronchopulmonary dysplasia (BPD) is a chronic respiratory condition primarily affecting infants born less than 28 weeks gestational age. BPD and the diagnostic criteria that define it have evolved since the initial description of the disease more than four decades ago.
Lannae, Strueby, Bernard, Thébaud
openaire +2 more sources
Lifelong pulmonary sequelae of bronchopulmonary dysplasia.
Current opinion in pediatrics, 2020PURPOSE OF REVIEW To summarize the current literature evaluating long-term pulmonary morbidity among surviving very preterm infants with bronchopulmonary dysplasia (BPD). RECENT FINDINGS BPD predisposes very preterm infants to adverse respiratory signs
Laura Sillers, S. Alexiou, E. Jensen
semanticscholar +1 more source
Bronchopulmonary dysplasia: a review
Archives of Gynecology and Obstetrics, 2013The prevalence of bronchopulmonary dysplasia (BPD), one of the most frequently occurring complications following preterm birth, is increasing due to increased survival of preterm infants.Systematic literature review.The etiology is multifactorial, with prematurity being a prerequisite for the development of BPD.
Zarqa, Ali +3 more
openaire +2 more sources
Ventilation Strategies in Severe Bronchopulmonary Dysplasia.
NeoReviews, 2020Bronchopulmonary dysplasia (BPD) is an acquired, developmental chronic lung disease that is a consequence of premature birth. In the most severe form of the disease, infants may require prolonged periods of positive pressure ventilation.
Kathleen Gibbs +4 more
semanticscholar +1 more source
Inflammation and bronchopulmonary dysplasia
Seminars in Neonatology, 2003Pulmonary inflammation is a key feature in the pathogenesis of bronchopulmonary dysplasia (BPD). This inflammatory process, induced by multiple risk factors, is characterized by the presence of inflammatory cells, cytokines and an arsenal of additional humoral mediators in the airways and pulmonary tissue of preterm infants with the condition.
openaire +2 more sources
Observations on bronchopulmonary dysplasia
The Journal of Pediatrics, 1979tension was related to the fetus's relative tolerance for hypoxia and the estimated and known levels of partial pressure of oxygen in the peripheral arterial blood of the fetus prior to delivery. The subsequent use of continuous positive airway pressure, positive end-expiratory pressure, and continuous negative pressure on the chest wall served to ...
openaire +2 more sources
Biomarkers in Bronchopulmonary Dysplasia
Paediatric Respiratory Reviews, 2013Bronchopulmonary dysplasia (BPD) is a complex disorder secondary to gene-environment interactions, and is the commonest chronic lung disease in infancy. There is no specific or effective treatment available to date for BPD. Since the aetiopathogenesis of BPD is multifactorial, involving diverse molecular signaling pathways, a variety of biomarkers ...
Anita, Bhandari, Vineet, Bhandari
openaire +2 more sources
Journal of Perinatology, 2020
To quantify and compare levels of potential biomarkers in neonates with (i) Bronchopulmonary dysplasia (BPD); (ii) BPD-associated pulmonary hypertension (BPD-PH); (iii) PH without BPD; and (iv) neonates without lung disease at ~36 weeks postmenstrual age.
M. Sahni +7 more
semanticscholar +1 more source
To quantify and compare levels of potential biomarkers in neonates with (i) Bronchopulmonary dysplasia (BPD); (ii) BPD-associated pulmonary hypertension (BPD-PH); (iii) PH without BPD; and (iv) neonates without lung disease at ~36 weeks postmenstrual age.
M. Sahni +7 more
semanticscholar +1 more source